Jacqueline Takere, Pharm D
About Jacqueline Takere, Pharm D
Jacqueline Takere, Pharm D, is the Director of U.S Medical Promotional Review - Hematology at Bristol Myers Squibb, with extensive experience in oncology, hematology, and hospital pharmacy.
Current Role at Bristol Myers Squibb
Jacqueline Takere serves as the Director of U.S. Medical Promotional Review in Hematology at Bristol Myers Squibb. Her role involves overseeing the medical review process for promotional materials related to hematology products. She ensures that all promotional content is scientifically accurate and complies with regulatory standards.
Previous Experience at Novartis Oncology
Prior to her current role, Jacqueline Takere worked at Novartis Oncology. From 2019 to 2021, she held the position of Associate Director, U.S. Oncology Medical. Before that, she was the Manager, U.S. Oncology Medical from 2016 to 2019. During her tenure at Novartis, she gained extensive experience in oncology medical affairs.
Roles at Englewood Hospital
Jacqueline Takere has a significant tenure at Englewood Hospital, where she held multiple roles. She served as the Director of the PGY-1 Pharmacy Residency Program from 2010 to 2016. She also contributed to the Pharmacy & Therapeutics Committee Formulary Management from 2005 to 2016. In addition, she was an Oncology Clinical and Investigational Drug Pharmacist from 2004 to 2016 and completed a Post-Doctorate PGY-1 Pharmacy Residency there from 2003 to 2004.
Educational Background
Jacqueline Takere earned her Doctor of Pharmacy from Howard University, where she studied from 1999 to 2003. She also holds a degree in Molecular Biology from the University of Maryland Baltimore County. Her educational background laid a strong foundation for her career in pharmacy and oncology.
Professional Expertise
With over 10 years of experience in oncology and hematology, Jacqueline Takere has a broad range of expertise. She is skilled in formulary management, development and implementation of drug policies and guidelines, and execution of clinical trials. Additionally, she has over 13 years of experience in hospital pharmacy, with a focus on clinical research and investigational drugs.